TrialBMC medicine2024

Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial.

Jia Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.